2A Pharma ApS
CVR 39391597 · Private limited company (ApS) · Active · Low risk
2A Pharma ApS is a Private limited company (ApS), founded on , based in Aalborg Øst. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.9% over the next 12 months, which is 0.6 times the average for Danish companies. 8 annual reports have been published, of which 2 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 263k and a net result of DKK -713k. CEO: Josephus Dirk Vestergaard Nieland.
Bankruptcy risk for 2A Pharma ApS
0.6 × the average (1.41%) · higher risk than 69% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 39391597
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (8 years)
- Address
- Kaolinvej 5
9220 Aalborg Øst - Municipality
- Aalborg
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 50k
- Employees
- 2 (2018)
- Auditor
- Cedra Godkendt Revisionsaktieselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 2 of 8 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 85.3% |
| Current ratio | 659% |
| Moves (last 2 years) | 1 |
| CEO changes in total | 1 |
| CEO's previous bankruptcies | 2 |
| Other companies at the address | 3 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK 587k | DKK 591k | DKK 159k |
| Net profit | DKK -713k | DKK 4,297 | DKK -43k |
| Equity | DKK 263k | DKK 976k | DKK 672k |
| Total assets | DKK 309k | DKK 1.7m | DKK 834k |
| Cash | DKK 75k | DKK 29k | – |
| Short-term debt | DKK 46k | DKK 755k | – |
| Avg. employees | 0 | 2 | – |
Latest annual report: Reporting class B · auditor's statement: Erklæring om udvidet gennemgang · Deloitte Statsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 181 | ||
| 1 Jan 2024 – 31 Dec 2024 | 177 | ||
| 1 Jan 2023 – 31 Dec 2023 | 175 | ||
| 1 Jan 2022 – 31 Dec 2022 | 184 | Late | |
| 1 Jan 2021 – 31 Dec 2021 | 187 | Late | |
| 1 Jan 2020 – 31 Dec 2020 | 169 | ||
| 1 Jan 2019 – 31 Dec 2019 | 161 | ||
| 1 Mar 2018 – 31 Dec 2018 | 169 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Josephus Dirk Vestergaard Nieland | Current | |
| CEO | Preben Bruun-Nyzell | ||
| Owner (100%) | 2A Pharma AB | Current | |
| Auditor | Cedra Godkendt Revisionsaktieselskab | Current | |
| Auditor | DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Founder | 2A Pharma AB | Current |
The CEOs' other companies
Josephus Dirk Vestergaard Nieland – 10 other companies, of which 4 bankrupt
- 2N Pharma ApS Bankrupt 27 Apr 2026
- 2N Pharma Holding ApS Bankrupt 27 Apr 2026
- AC 2,0 ApS Bankrupt 28 Jun 2023
- ACINDRIA ApS Bankrupt 16 Jun 2022
- AC 2,0 Holding ApS Active
- CPT.one BIOTECH ApS Fusioneret
- FIRMA AF 2008 ApS Opløst
- MALERFIRMAET BENT PEDERSEN A/S Active
- METANOVI ApS Opløst
- Neurometa Therapeutics ApS Active
Preben Bruun-Nyzell – 6 other companies, of which 2 bankrupt
- 2N Pharma ApS Bankrupt 27 Apr 2026
- 2N Pharma Holding ApS Bankrupt 27 Apr 2026
- JTP HANDEL ApS Opløst
- Neurometa Therapeutics ApS Active
- SRS FOOD-SERVICE A/S Fusioneret
- SRS SERVICE & RENGØRINGS SELSKAB A/S Fusioneret
Address history (2 moves)
| Kaolinvej 5, 9220 Aalborg Øst | |
| Niels Jernes Vej 10, 9220 Aalborg Øst | |
| Niels Jernes Vej 12, 9220 Aalborg Øst |
Employees per year
Other companies at the same address
- JV INVEST ApS Active
- MALERFIRMAET BENT PEDERSEN A/S Active
- Neurometa Therapeutics ApS Active
- TRYKIT ApS Compulsorily dissolved
Similar companies in Aalborg
- Neurometa Therapeutics ApS Aalborg Øst
- Biogenity ApS Aalborg Øst
- Methyl Detect ApS Aalborg Øst
- EEGTRAINING NORD ApS Vestbjerg
- DNASENSE ApS Aalborg Øst
- C4PAIN ApS Aalborg
- OLE USSING ApS Aalborg
- REDO-Neurosystems ApS Aalborg
- 2N Pharma ApS Aalborg Øst
- ClearDynamic ApS Nørresundby
- The Froglet IVS Aalborg
- EMProS IVS Gistrup
Questions and answers about 2A Pharma ApS
Has 2A Pharma ApS gone bankrupt?
No, 2A Pharma ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of 2A Pharma ApS?
Our model estimates a bankruptcy risk of 0.9% over the next 12 months (low risk), which is 0.6 times the average for Danish companies.
Who is the CEO of 2A Pharma ApS?
Josephus Dirk Vestergaard Nieland is the CEO of 2A Pharma ApS.
Who is the auditor of 2A Pharma ApS?
2A Pharma ApS most recently used Cedra Godkendt Revisionsaktieselskab.
When was 2A Pharma ApS founded?
2A Pharma ApS was founded on 27 February 2018.
What is the equity of 2A Pharma ApS?
Equity was DKK 263k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.